Literature DB >> 10550673

The human homologue of the bovine leukemia virus receptor BLVRcp1 is the delta-subunit of adaptor-related AP-3 protein that does not bind the BVLgp51.

J Ban1, J Hlavaty, O Orlik, G A Splitter, C Altaner.   

Abstract

The relationship between the putative bovine leukemia virus receptor gene (BVLRcp) and the susceptibility of human cells to BLV infection was studied. Three cDNA clones encoding different portions of the human equivalent of bovine BLVRcp1 were isolated by DNA-DNA hybridization by comparison of the human cDNA clones to bovine BLVRcp1. Amino acid sequence indicated that the human sequence encodes the delta subunit of the AP-3 adaptor-related protein. When the recombinant human homologue BLVRcp2 was expressed in E. coli, it failed to bind the BLVgp51. However, the BVLVgp51 binding ability was restored when the chimerical BLVRcp molecule was prepared by exchanging 5' ends between bovine and human BLVRcp cDNAs. This finding implies that this BLVgp51 binding site is present only on the bovine BLVRcp and therefore its human homologue cannot be recognized by BLVgp51. This might also explain the resistance of human cells to BLV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550673     DOI: 10.1007/s007050050722

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  2 in total

Review 1.  Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

Authors:  J Overbaugh; A D Miller; M V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

Review 2.  Interrelated Oncogenic Viruses and Breast Cancer.

Authors:  Samia Afzal; Khadija Fiaz; Afifa Noor; Amira Saleem Sindhu; Asma Hanif; Ayesha Bibi; Muhammad Asad; Saba Nawaz; Saba Zafar; Sidra Ayub; Syeda Bariyyah Hasnain; Muhammad Shahid
Journal:  Front Mol Biosci       Date:  2022-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.